Platelets are small, anucleated cells that participate in primary hemostasis by forming a hemostatic plug at the site of a blood vessel's breach, preventing blood loss. However, hemostatic events can lead to excessive thrombosis, resulting in life-threatening strokes, emboli, or infarction. Development of multi-scale models coupling processes at several scales and running predictive model simulations on powerful computer clusters can help interdisciplinary groups of researchers to suggest and test new patient-specific treatment strategies.
microparticles, and vascular changes, platelets also promote cancer and inflammation [4] [5] [6] . Therefore, there is a great need to understand more platelet-leukocyte-endothelial interactions ( Fig. 5.1 ) and translate that into more effective, less toxic therapies.
A major challenge in quantitative understanding of hemostasis/thrombosis is to integrate various processes occurring during thrombus development. To predict how variations of multiple factors associated with platelet activity affect thrombus development is of great biomedical importance. However, there are significant challenges in developing such understandings. For instance, platelet-vessel wall receptor-ligand interactions occur at nanometer scale, whereas blood flow dynamics in the vicinity of a thrombus is a macroscopic event developing over the scale of hundreds of micrometers to millimeters. Coupling various processes is a complex, challenging task.
By reviewing main platelet functions, their roles in hemostasis/thrombosis, and computational approaches to simulate clotting events, this chapter establishes a rationale for a systems approach to platelet physiology. These include modeling of coagulation reactions, platelet activation, platelet dynamics, platelet-platelet interactions, and blood flow. The integrative modeling approaches are described to provide the basis for multi-scale computational models of thrombus development. First, biological background on platelet functioning is given, including platelet adherence and activation, intracellular and extracellular signaling, relation to tumor metastasis, and global approaches to study plateletvessel wall interactions. Then, several recent integrative modeling methods of thrombus development involving cellular signaling, platelet-platelet, platelet-flow, and platelet-wall interactions are highlighted. Finally, a concluding perspective is offered on the role of platelets in hemostasis/thrombosis and tumor progression as well as the role of system biology in testing new therapeutic targets. thrombasthenia, a bleeding disorder. When fibrinogen binds to the integrin, a cascade of downstream events, which include cytoskeletal rearrangements via talin and other signaling involving rous sarcoma (SRC) and focal adhesion kinase (FAK)-tyrosine kinases [12] , is set in motion. Equally important is the presence of collagen receptors at the surface of the platelet, the better known of which are GPVI and α2β1. GPVI in particular seems to have a prominent role during collagen exposure to platelet surface and subsequent activation [12] . Platelets also express the C-type lectin receptor (CLEC-2, which triggers a downstream signaling cascade similar to that of GPVI, including activation of the spleen tyrosine kinase (Syk)) [12] .
G-protein-coupled receptors include the thrombin receptor, adenosine diphosphate (ADP) receptors (P2Y1, P2Y12 which is a target for several "antiplatelet" drugs in thrombotic disease treatment) [3, 13] , and thromboxane A2 receptor. They are activated in response to soluble factors from the blood. Exposure of the subendothelial matrix provides additional potent activators of platelet activation and coagulation. Platelet receptors recognize matrix components, collagen (via α2β1, GPVI), and laminin (via α6β1). Targeting of the laminin receptor, like the integrin α6β1, has been shown to be a promising strategy in the treatment of arterial thrombosis [14] . Recently, platelets were found to express CXCR6, the receptor specific to chemokine CXCL16. CXCL16 present on atherosclerotic lesions was found to enhance platelet adhesion to the endothelium after high arterial shear stress and to injured vascular wall [15] . Other cell surface proteins on platelets, such as Eph kinases and EphrinB1 [16] , semaphorins [17] or Gas6 receptors [18] , may promote thrombus formation. Gap junction channels, such as connexin 37 [19] , may also enhance thrombus formation.
The list of platelet cell surface receptors or adhesion molecules will likely continue to grow, adding to complexity of platelet interactions and function. For instance, by expressing CD40-L, Fc receptors to immunoglobulins, and toll-like receptors [5] , platelets serve as effectors in the immune system. Platelet-derived microparticles containing pro-inflammatory cytokines such as IL-1β contribute to inflammation [6] .
Intracellular Cell Signaling and Inter-platelet Signaling
Resulting from those diverse ligand-receptor stimuli ( Fig. 5.2 ), downstream signaling events involve phospholipid metabolism, generation of cAMP and cGMP second messengers, and Ca 2+ release from the dense tubular system. These pathways lead to cytoskeletal reorganization, calpain activation, and signal amplification and diversification due to protein and lipid kinases. Phosphatase activity increases too [20] . Many of these pathways intersect or interact with each other in a complex fashion. Besides outside-inside signaling, there is also inside-outside signaling, as in the case of αIIbβ3 integrin activation [12, 21] .
Extraplatelet Signaling
Upon platelet stimulation, alpha or dense granule release occurs, leading to platelet activation amplification, since the released substances (fibrinogen, vWF,ADP, thromboxane A2, thrombospondin-1) will further activate platelets and contribute to hemostasis. One adaptive measure is to induce blood vessel constriction, which is achieved through thromboxane A2. However, alpha granules release not only prothrombotic but also proangiogenic (VEGF) and anti-angiogenic (endostatin, thrombospondin) factors [22] [23] [24] [25] . Intensively studied are platelet microparticles and exosomes. Microparticles are shed from membranes and their size varies from 100 to 1000 nm [26] , while exosomes are secreted and overall smaller (30-100 nm) [27] . Microparticles are shed from the platelet membrane and carry tissue factor activity, thus being procoagulant [12, 28] . Exosome secretion from platelets has also been described, but their role is less well known [29] . Inflammation contributes to thrombus formation through the interaction of platelets with leukocytes (neutrophils and monocytes) [30, 31] . Indeed, thrombosis could more generally be seen as an effector of innate immunity [32] . Moreover, neutrophils also contribute to thrombus formation, including via formation of neutrophil extracellular traps (NET) [33] [34] [35] [36] [37] .
When a blood vessel is injured, the subendothelial matrix is exposed, and matrix components such as the collagens or laminins serve as potent activators of platelet activation. Furthermore, endothelial cells release prothrombotic factors such as vWF from their Weibel-Palade bodies. Interestingly, vWF release from the endothelial Weibel-Palade bodies is dependent on essential autophagy genes Atg5 or Atg7, and pharmacological inhibitors of autophagic flux lead to increased bleeding time [38] . On the other hand, the endothelium also releases substances that are inhibitory to platelet activation, by secreting nitric oxide (NO) and the downstream modulation of cGMP levels [39] [40] [41] [42] [43] , or by secreting prostacyclin(PGI2) [44] .
On a different scale, platelet contraction forces depend on microenvironment stiffness [45] and platelet adhesion and spreading depends on local microenvironment geometry [46] . Stresses developed by contracting platelets significantly alter thrombus internal structure and were recently shown to strongly deform embedded erythrocytes [47] . Vessels can be made susceptible to injury depending on vessel geometry, biophysical and rheological forces from the blood flow that will produce turbulence and shear. Models are being developed, where the role of vWF is still being found to be crucial [48] . Progression of an injured endothelium, resulting from a combination of flow shear, inflammatory state, and dyslipidemia, results in atherosclerosis and atheroma plaques, which by themselves lead to specific atheroma-platelet interactions [15, 44] .
Platelets and Tumor Metastasis Through the Vessel Wall
Apart from their role in thrombosis and inflammation/immunity, platelets are also currently under intense scrutiny for their role in cancer metastasis dissemination. Indeed, a study has found that interactions between platelets and tumor cells induce an invasive mesenchymallike phenotype and enhance in vivo metastasis. This effect is mediated by platelet-derived TGFβ, which activates the Smad and NF-κB pathways in cancer cells [4] . Specific to vessel wall effects, tumor cell-activated platelets secreted ADP, which facilitates cancer cell penetration past blood vessels. The P2Y2 receptor on blood vessel cells is necessary for this effect [49] .
Global Approaches in Studying Platelet-Vessel Wall Interactions
To discover molecular mechanisms of platelet interactions with the vessel wall, researchers have been relying on narrowed and focused approaches (Fig. 5.3 ). One example is observing human disease and trying to pin down the molecular defect. Then one might want to search for partners of known actors. Subsequently, to confirm the relevance, one might pursue on knocking down or knocking out an element and observing the cell or organism for modified behaviors. More recently, researchers have been adding new global approaches in the field of biology, enriching knowledge through global and systemic approaches [50] . These new global approaches include:
1.
Mutagenesis screening by N-ethyl-N-nitrosourea (ENU). For example, BcL-xL was discovered to regulate platelet half-life or platelet number [51] .
2.
Genome-wide association studies (GWAS). Human genomic variations are associated with cardiovascular outcomes, platelet size, or number, as reported by European study consortiums [52] . Jones et al. found that single nucleotide variants in platelet endothelial aggregation receptor 1 (PEAR1), guanine nucleotide exchange factors (GEFs) for Rho family GTPases (VAV3), and IP3 receptor (ITPR1) were associated with modified platelet response to platelet agonists [53] .
3.
Transcriptomics. Rowley et al. recently reported a comprehensive transcriptome study of human and mouse platelets [54] . This approach led to the discovery of connexin 37 in platelet aggregation [19] .
4.
Proteomics. Comprehensive platelet proteomics have been performed [55] and can be further narrowed down to subfields as "secretome" or "phosphoproteome" [56] . These proteomic studies revealed that secretogranin III, cyclophilin A, and calumenin were secreted by platelets after thrombin stimulation and found in atherosclerotic plaques [57] and nitrous oxide-treatment abrogated platelet activation by thrombin and prevented thrombin-induced translocation of gelsolin, filamin, 14-3-3 ζ, phosphatidylinositol 3-kinase-gamma isoform, and growth factor receptor-bound protein 2 (Grb2) [58] .
5.
Network analysis. Network analysis tools are being developed and databases are being made available online. For example, cPlateletWeb (http:// plateletweb.bioapps.biozentrum.uni-wuerzburg.de) is an Internet-based platform organizing signaling network [59, 60] . A study based on PlateletWeb found a novel interaction between vasodilator-stimulated phosphoprotein and Abelson interactor 1 in human platelets [61] . Another database is Reactome (http:// www.reactome.org), where extensive data have been collected, analyzed, and grouped in different pathways [62] .
6.
Informatics for modeling and simulations. Bioinformatics can be used to develop models for simulating platelet function, thrombus formation associated with proor anticoagulant gradients, and different flow conditions [63] [64] [65] [66] [67] [68] [69] . Indeed, thrombus formation studies have mostly focused on separate components of thrombogenesis, which can be numerous and subgrouped into categories: coagulation cascades of blood coagulation factors, platelet adhesion to the vascular wall, platelet aggregation among themselves, internal platelet activation phenomena, platelet substance release and amplification reaction, white blood cells'roles in thrombus formation, vessel wall product release, vessel wall injury and exposure of thrombogenic elements, atheroma genesis, and blood flow shear variation and impact.
Integrative Multi-scale Modeling Approaches
Integrating the relative role of each of the mentioned elements to model thrombus formation has been challenging. Various modeling approaches have been proposed, that integrate a certain number of processes or scales, and tested with the assistance of simulations implemented on large computer clusters (see [63, 65, 70, 83] for review). One target goal for future research would be to improve modeling ability to predict platelet/vessel wall behavior and thrombus formation by integrating simulations of the molecular signature characteristics, mechanical properties of agonist/antagonist, blood flow and viscoelastic properties of a blood vessel. Below we outline several existing modeling approaches that combine several scales.
Explicit incorporation of single platelet dynamics into a three-dimensional thrombus formation model has been described in Pivkin et al. [71] where each platelet was represented in a simplified way as a spherical object, while red blood cells were treated using continuum submodel describing their density. The model also included an ADP-induced platelet activation mechanism. Model simulations accurately reproduced the thrombus growth rate as a function of blood velocity obtained in experiments [72] .
Fogelson and Guy developed a microscale platelet aggregation model in which individual platelets were modeled as fluid-filled closed membranes immersed in a viscous liquid [73] . This model allowed for simulations of individual platelet motion and their interactions with each other and with surrounding medium. In the model by Mody and King [74] , the hydrodynamic effects of the oblate spheroidal shape of platelets and the proximity of a wall on cell-cell collisions were investigated. Collision time and contact area and collision frequency were compared between spherical shape vs. platelet-type oblate shape on one hand and presence or not of a proximal bounding wall. The approach used calculation of forces and torques acting on each particle in the fluid system (gravity, bond forces, and repulsion between two surfaces in close proximity). The study showed that the contact time between two platelets during collision close to the wall was greater than the contact time during a collision far from the wall. The wall proximity had a greater influence on plateletplatelet collisions than on sphere-sphere collisions. The method also used Huang and Hellums' mathematical model of the shear-induced platelet aggregation [75] [76] [77] , where high shear resulted in increased platelet aggregation.
Leiderman and Fogelson [78] described a model of blood coagulation under flow that included coagulation biochemistry, chemical activation, and deposition of platelets, and a two-way interaction between fluid dynamics and growth of platelet mass. Expanding on a previously published Kuharsky and Fogelson model [79] , this approach now described how tissue factor threshold triggered production of thrombin and how the wall shear rate and near-wall increased platelet concentration affected thrombus growth. The porous nature of the thrombus, allowing for advective and diffusive transport within itself, was also accounted for in the extended model. Xu et al. [63, [80] [81] [82] [83] proposed a multi-scale model-coupling submodels of coagulation reactions, platelet dynamics, and blood flow, where platelets were represented as extended objects with fluctuating boundaries based on the cellular Potts model [84] .
The importance of quantifying transport of coagulation factors within thrombus microenvironment was emphasized in Ref. [69] . By combining in vitro experiments and continuum-modeling approach of thrombus hydrodynamics, authors showed that both diffusivity and advection of blood proteins through the porous thrombus structure affect platelet-thrombus interaction and play an essential role in blood clot growth dynamics. Following this work, Stalker et al. demonstrated, using mouse injury model, that regional platelet-packing density emerged in parallel with differences in intrathrombus molecular transport and predicted that these differences affect thrombus growth and stability [85] .
Wu et al. [86] presented a three-dimensional multi-scale platelet-blood flow-vessel wall interaction model, which combined three biological scales crucial for the early platelet aggregation. The model included hybrid cell membrane submodel of platelet elasticity, stochastic receptor-ligand binding submodel of cell adhesion kinetics and Lattice Boltzmann submodel of blood flow. Adhesion kinetics involved specific receptor-ligand pairs, namely vWF-GpIb complexes. At subcellular level, to simulate vWF-GpIb and GpIbvWF-GpIbαbinding, individual molecules were represented by elastic springs. This was justified by the demonstration that the receptor-ligand binding is probabilistic in nature. Individual filaments of the cytoskeleton network of platelet membrane were modeled as coarse-grained harmonic potentials. At cellular level, a novel continuum description of the cell membrane was used. The subcellular and cellular components were integrated by distributing GpIbα receptors over verticies of the cytoskeleton network and by superimposing the lipid bilayer and the network. The model allowed investigation of how platelet stiffness, GPIb receptor expression, and platelet-platelet interaction affect plateletwall adhesion quantified in terms of platelet pause time. To reduce the computational time cost, the model was implemented on graphical processing units (GPUs) computer cluster. Predictive simulations revealed that platelet deformation, interactions between platelets in the vicinity of the vessel wall, as well as the number of functional GPIbα platelet receptors played significant roles in the platelet adhesion to the injury site ( Fig. 5.4 , from Ref. [86] ).
Recently, a multi-scale model was presented in Flamm, Diamond et al. [64, 65, 87] , which included four components: the fluid flow (using a lattice Boltzmann method), the transport of soluble substances (using convection-diffusion-reaction equations), motion and binding of platelets leading to their deposition (using a lattice kinetic Monte Carlo algorithm), and the activation state of each platelet (using a neural network for cellular signaling). A pairwise agonist scanning approach had been found to allow handling of large datasets of measured calcium mobilization to predict an individual's platelet responses to pairwise combinations of ADP (which activates P2Y1/P2Y12 receptors), U46619 (which has properties similar to Thromboxane A2), and convulxin (which activates GPVI receptor to collagen). A neural network for cellular signaling was used to predict patient-specific responses to drugs. The resulting simulations were compared with experimental results in a system using blood flowing on collagen in microfluidic devices at different shear rates. The simulations were used to predict the individual's drug sensitivity to cyclooxygenase (COX) inhibitors and P2Y1 receptor antagonists in three different blood donors.
Perspective and Conclusions
Increasing and organizing our knowledge on platelet-vessel wall interactions and combining it with novel multi-scale computational models to test new biological hypothesis will help devise treatments for human disease where excessive thrombosis occurs, while attempting to minimize the risk of bleeding. Moreover, platelets and vessels are not only implicated in "pure" thrombotic states and inflammatory disease but also in other pathological processes such as cancer and metastases. Furthermore, how both platelets and blood vessels may contribute to tumor growth and tumor dissemination can be by itself a part of a systems approach to cancer biology. Relying only on in vivo studies is impractical and time consuming. Genetic knockout animal models have their own limits, as nonhuman animals' biology differs from human biology in many aspects, and a complete functional knockout might not yield information on certain conditions, where a dosage effect or a mutated state might be the actual determinant pathogenesis. While hypothesis-based experiments are being performed, concomitantly developing and refining multi-scale models and running simulations on powerful computer clusters will enable biomedical community to accelerate testing of new therapeutic targets. Systems biology is thus becoming a novel empowering tool to devise new less toxic treatments more efficiently and economically. Platelets and vessel walls interact in multiple ways. Platelets and vessel wall cells express adhesion molecules, surface receptors, and release substances that initiate or regulate cascading thrombosis events. Matrix components of the vessel wall, when blood flow is exposed through a damaged endothelium, also elicit clotting reactions from blood cells. Moreover, blood cells and endothelial cells also produce microparticles and microvesicles that carry procoagulant activity Platelets express a diversity of cell surface receptors and chemical substances that interact with the vessel wall components during hemostasis. Downstream signaling events take place that involve phospholipid signalization, Ca 2+ flux, calpain activation, cAMP-and cGMPlevel modulation, cytoskeletal players and their modulators and diverse kinases. Many of these pathways intersect or interact with each other in a complex manner Systems approach to hemostasis control by platelet-blood vessel interaction. A highly informative approach is based on multi-scale analysis of human bleeding disorders at biochemical, molecular, genetic, and organismal levels 
